Efficacy and Tolerability of Aripiprazole in a Nigerian Cohort with First-episode Psychosis: A Post-marketing Survey
S. O. Olotu, I. O. Agbonile, J. O. Omoaregba & B. O. James · International Neuropsychiatric Disease Journal · 2017
Background: Individuals with first episode psychoses often discontinue pharmacotherapy due to poor symptom remission and/or intolerable side effects. Aripiprazole has been reported to show good efficacy with low side effect profiles in Caucasians. No studies have been conducted t...
Open access
Research Article
10.9734/INDJ/2017/34977